Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pneumovax
Pharma
Merck touts Capvaxive's potential to provide protection for kids
Approved 15 months ago as the first pneumococcal disease vaccine for adults, Merck’s Capvaxive has shown potential in those ages 2 to 17.
Kevin Dunleavy
Sep 11, 2025 11:12am
Merck ramps up 'Don't Skip' TV push for shots in older adults
Jan 31, 2022 9:00am
Merck childhood vaccine PSA stars celebrity couple and family
May 21, 2021 10:30am
Merck's M&A appetite very much in play, exec says
Apr 29, 2021 12:29pm
Merck wins speedy FDA review for 15-strain pneumonia vaccine
Jan 12, 2021 10:50am
Merck takes a $2.5B pandemic hit but sees a COVID-19 boost, too
Oct 27, 2020 12:14pm
